Head-to-head · computed 2026-08-11
LifeMD vs TMates
LifeMD: LifeMD attaches a $149/month program fee to medication pricing; its compounded tirzepatide all-in figure ($597) is the highest in our index, though its insurance-navigation pathway for brand products is a genuine strength. TMates: TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
Tirzepatide
| LifeMD | TMates | |
|---|---|---|
| All-in maintenance | $597/mo | $297/mo |
| Best plan rate | $597/mo | $167/mo |
| 12-month total | $7,164 | $2,004 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, TMates's $297 a month undercuts LifeMD's $597 by $300 a month at the 10 mg/wk maintenance basis — $3,600 across a year. TMates's figure is reported (captured 2026-07-14) and LifeMD's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
LifeMD's tirzepatide ladder runs $597 a month billed monthly. TMates's runs $297 a month billed monthly, and $167 a month on a twelve-month plan. On the twelve-month basis TMates's $2,004 beats LifeMD's $7,164 by $5,160 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| LifeMD | TMates | |
|---|---|---|
| All-in maintenance | $348/mo | $249/mo |
| Best plan rate | $348/mo | $158/mo |
| 12-month total | $4,176 | $1,896 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, TMates's $249 a month undercuts LifeMD's $348 by $99 a month at the 2.4 mg/wk maintenance basis — $1,188 across a year. TMates's figure is reported (captured 2026-07-14) and LifeMD's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
LifeMD's semaglutide ladder runs $348 a month billed monthly. TMates's runs $249 a month billed monthly, and $158 a month on a twelve-month plan. On the twelve-month basis TMates's $1,896 beats LifeMD's $4,176 by $2,280 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
TMates carries no membership fee against LifeMD's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, LifeMD is dose-flat — the price survives titration — while TMates's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. LifeMD works with insurance pathways while TMates is cash-pay only — decisive if you hold coverage worth using (the indication doors map when you do), irrelevant if you're paying cash either way.
Structure, side by side
LifeMD
- Membership$149/mo
- Dose policyFlat at published rate
- CommitmentMonth-to-month
- CancellationCancel anytime
- PharmacyPartner pharmacies
TMates
- MembershipNone
- Dose policyStructured titration; medication and provider visits included in price
- Commitment12-month plan or month-to-month; substantial difference in rates
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
What our desk is watching on each
LifeMD: Highest all-in compounded tirzepatide in the index; the value case rests on clinical service and insurance help, not price.
TMates: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Questions people ask
Is LifeMD or TMates cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does LifeMD vs TMates miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do LifeMD and TMates cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $7,164 at LifeMD and $2,004 at TMates — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: LifeMD · TMates. Official sites: LifeMD ↗ · TMates ↗. Nothing here is medical advice.